This summer, students and professionals passionate about pharmaceutical innovation have a unique opportunity to gain hands-on experience in modern drug development.
The Introduction to Preclinical Drug Discovery course, hosted by Radboud Summer School in collaboration with Radboud University, HAN University of Applied Sciences, and Pivot Park, provides participants with a comprehensive overview of today’s pharmaceutical R&D process.
Through interactive sessions and expert guidance, attendees will explore key stages of drug discovery — from target identification to preclinical testing. The course also delves into the latest technologies and challenges in the field, offering valuable insights into the future of drug development.
Participants will learn from leading experts in the field, including Floris Rutjes, Pedro Hermkens, Dennis Löwik, and Joost Uitdehaag.
When: The course takes place this summer as part of Radboud Summer School.
For whom: Ideal for students and early-career professionals interested in the science behind drug development.
Where: Apply now via Radboud Summer School
As of June, the Leiden Bio Science Park team has been joined by Gerwin Zomer, who steps into the role of Account Manager Physical Living Environment. To get to know him a bit...
Researchers at the Leiden University Medical Center (LUMC) have announced promising early results from a clinical trial using lab-grown insulin-producing islet cells derived from...
VarmX has received IND approval for its Phase 3 trial of VMX‑C001, a recombinant factor X variant designed to neutralize FXa‑inhibiting anticoagulants during emergency surgery. Backed by robust Phase 1 data and boosted by a €15 million EIC investment, this step positions VMX‑C001 to meet a gap in urgent haemostasis care.